These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3166537)

  • 1. The efficacy of antimicrobial treatment in Campylobacter pylori-associated gastritis and duodenal ulcer.
    Hirschl AM; Hentschel E; Schütze K; Nemec H; Pötzi R; Gangl A; Weiss W; Pletschette M; Stanek G; Rotter ML
    Scand J Gastroenterol Suppl; 1988; 142():76-81. PubMed ID: 3166537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori.
    Hui WM; Lam SK; Ho J; Ng I; Lau WY; Branicki FJ; Lai CL; Lok AS; Ng MM; Fok J
    Am J Med; 1989 Jun; 86(6A):60-5. PubMed ID: 2660558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Campylobacter pylori in patients with chronic gastritis and gastric and duodenal peptic ulcer].
    Kolarski V; Tsenova V; Shopova K; Vasileva E; Petrova D
    Vutr Boles; 1989; 28(2):58-62. PubMed ID: 2763525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Campylobacter pylori and pathology of the gastro-duodenal mucosa. Critical review of clinico-experimental and therapeutic contributions].
    Lazzaroni M; Bianchi Porro G
    Medicina (Firenze); 1989; 9(1):9-18. PubMed ID: 2661960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Campylobacter pylori and treatment of duodenal ulcer].
    Zelenková J; Toman R; Bielaszewská M; Hanika J; Zeman V
    Vnitr Lek; 1990 Jun; 36(6):573-9. PubMed ID: 2219764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
    Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
    Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity of Campylobacter pylori in the upper gastrointestinal tract--implications for modern therapy.
    Lambert JR; McLean AJ
    Med J Aust; 1989 Aug; 151(3):120-2. PubMed ID: 2755371
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease.
    Bayerdörffer E; Ottenjann R
    Scand J Gastroenterol Suppl; 1988; 142():93-100. PubMed ID: 3047854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of Campylobacter pylori in duodenal ulceration treated with an H2-antagonist.
    Ho J; Hui WM; Ng I; Lam SK
    Aliment Pharmacol Ther; 1989 Jun; 3(3):315-20. PubMed ID: 2577695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Campylobacter pylori-associated gastritis: attempts to eradicate the bacteria by various antibiotics and anti-ulcer regimens.
    Glupczynski Y; Burette A; Nyst JF; De Prez C; De Koster E; Deltenre M
    Acta Gastroenterol Belg; 1988; 51(4-5):329-37. PubMed ID: 2979039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of Campylobacter pylori in gastroduodenal pathology].
    Sirigu F; Capeccioni S; Dessì A; Masia AM; Usai P
    Recenti Prog Med; 1990 Mar; 81(3):142-5. PubMed ID: 2359867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori density on antral mucosa of patients with and without duodenal ulceration.
    Queiroz DM; Quintao JG; Rocha GA; Barbosa AJ; Mendes EN
    Gastroenterol Clin Biol; 1991; 15(6-7):558. PubMed ID: 1916140
    [No Abstract]   [Full Text] [Related]  

  • 13. Campylobacter pylori. A new era in gastroduodenal disorders?
    Gill HH; Kalro RH; Desai HG
    J Assoc Physicians India; 1990 Feb; 38(2):147-50. PubMed ID: 2199425
    [No Abstract]   [Full Text] [Related]  

  • 14. Campylobacter pylori as a pathogenetic factor in duodenal ulcer: the case for.
    Graham DY
    Scand J Gastroenterol Suppl; 1989; 160():46-52. PubMed ID: 2814348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Campylobacter pylori and peptic ulcer disease.
    Graham DY
    Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):615-25. PubMed ID: 2642447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.
    Marshall BJ; Goodwin CS; Warren JR; Murray R; Blincow ED; Blackbourn SJ; Phillips M; Waters TE; Sanderson CR
    Lancet; 1988 Dec 24-31; 2(8626-8627):1437-42. PubMed ID: 2904568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Campylobacter pyloridis and gastroduodenal pathology].
    Thomas CM; Rosenau A; Tulliez M; Paul G; Gaudric M; Neuman M; Guerre J
    Ann Med Interne (Paris); 1987; 138(6):403-6. PubMed ID: 3434925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Campylobacter (Helicobacter) pylori. Is peptic disease a bacterial infection?
    Chamberlain CE; Peura DA
    Arch Intern Med; 1990 May; 150(5):951-5. PubMed ID: 2184791
    [No Abstract]   [Full Text] [Related]  

  • 19. Duodenal ulcer disease: what role does Campylobacter pylori play?
    Smith AC
    Scand J Gastroenterol Suppl; 1989; 160():14-8. PubMed ID: 2683020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Campylobacter pylori in patients with gastroduodenal disease].
    Fukuda Y; Yamamoto I; Inoue H; Mikami J; Tamura K; Satomi M; Shimoyama T
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):575-88. PubMed ID: 2321983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.